Tempus AI

Founded: 2015 · Chicago, United States · 1000+ employees · Public

About Tempus AI

Tempus AI is a healthcare technology company that leverages data and artificial intelligence to provide precision medicine services, including diagnostics, for various therapeutic areas such as oncology, cardiology, radiology, and depression. The company has built one of the world's largest libraries of clinical and molecular data, along with an operating system to make this data accessible and useful for personalized patient care and accelerating therapeutic discovery.

Company Details

Website
https://www.tempus.com
Funding
IPO
Total Raised
$1.3B
Stock Ticker
TEM
LinkedIn
https://www.linkedin.com/company/tempus-ai

Specializations

  • HealthTech
  • AI/ML
  • Precision Medicine
  • Oncology
  • Genomic Diagnostics

Certifications

  • CAP-accredited
  • CLIA-certified

Products & Solutions (9)

ProductCategorySub-CategoryDescription
Algosresearch-developmentScientific ComputingAI-driven algorithmic diagnostics for personalized cancer treatment.
Davidresearch-developmentAcademic WritingGenerative AI clinical co-pilot integrated into EHR platforms.
Hubresearch-developmentLab Management & ELNStreamline test ordering, results, and personalized insights for healthcare providers on desktop and mobile.
Lensresearch-developmentResearch DiscoveryFind, access, and analyze multimodal Tempus data for research and discovery.
Nextresearch-developmentResearch DiscoveryAI-enabled platform to identify and close care gaps for precision medicine.
Paige Predictresearch-developmentDrug Discovery AIAI-powered digital pathology for biomarker prediction from H&E images.
Tempus ECG-Low EF Softwareresearch-developmentDrug Discovery AIAI software for early identification of low LVEF from ECGs.
Tempus ONEresearch-developmentDrug Discovery AIPrecision medicine and genomics analysis
Trialsresearch-developmentDrug Discovery AIAI-powered patient identification to accelerate clinical trial enrollment and discovery.

Notable Customers

  • Pfizer
  • Novartis
  • Eli Lilly
  • AstraZeneca
  • Northwestern Medicine